Dr. Nieva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
# NOR8302E
Los Angeles, CA 90089Phone+1 323-865-3105Fax+1 323-865-0061
Summary
- Dr. Jorge Nieva is an oncologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Los Angeles General Medical Center, Keck Hospital of USC, and USC Norris Comprehensive Cancer Center. He received his medical degree from University of California, Irvine, School of Medicine and has been in practice 24 years. He also speaks multiple languages, including Spanish. He specializes in head & neck cancer, hematologic oncology, and thoracic cancer and is experienced in amyloidosis, mesothelioma, hematologic oncology, lung cancer, and myelodysplasia. He has more than 100 publications and over 500 citings.
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1997 - 2000
- University of California, Irvine, School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2026
- MT State Medical License 2007 - 2016
- WY State Medical License 2007 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 Start of enrollment: 2017 Mar 10
- Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma Start of enrollment: 2018 Oct 04
- Join now to see all
Publications & Presentations
PubMed
- 406 citationsIntravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansCaroline J. Breitbach, James M. Burke, Derek J. Jonker, Joe Stephenson, Andrew R. Haas
Nature. 2011-09-01 - 4 citationsPan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.Misako Nagasaka, Yasmine Baca, Joanne Xiu, Jorge Nieva, Ari Vanderwalde
BMC Cancer. 2023-10-18 - 96 citationsCytomorphology of circulating colorectal tumor cells:a small case series.Dena Marrinucci, Kelly Bethel, Daniel C. Lazar, Jennifer Fisher, Edward Huynh
Journal of Oncology. 2010-01-06
Press Mentions
- Rising Standards in Regulatory Decisions Highlight Challenges in Drug Development in Lung CancerFebruary 7th, 2023
- FDA Committee Unanimously Rejects 131-I-Omburtamab for NeuroblastomaOctober 28th, 2022
- FDA Panel Puts PI3K Inhibitors for Blood Cancers on NoticeApril 22nd, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: